Intra-abdominal hypertension and abdominal compartment syndrome in the critically ill liver cirrhotic patient-prevalence and clinical outcomes. A multicentric retrospective cohort study in intensive care.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
02
2021
accepted:
28
04
2021
entrez:
13
5
2021
pubmed:
14
5
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Liver cirrhosis and ascites are risk factors for intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS); however, data is scarce. We aimed to determine the prevalence of IAH/ACS in a population of critically ill cirrhotic patients with acute medical illness in intensive care and to assess for risk factors and clinical outcomes. This was a multicentric retrospective cohort study including two general ICUs and pooled data from a multicentric study between January 2009 and October 2019. A total of 9,345 patients were screened, and 95 were included in the analysis. Mean age was 56.7±1.3 years, and 79% were male. Liver cirrhosis etiology included alcohol in 45.3% and alcohol plus hepatitis C virus in 9.5%. Precipitating events included infection in 26% and bleeding in 21% of cases. Mean severity score MELD and SAPS II were 26.2±9.9 and 48.5±15.3, respectively, at ICU admission. The prevalence of IAH and ACS was respectively 82.1% and 23.2% with a mean value of maximum IAP of 16.0±5.7 mmHg and IAH grades: absent 17.9%, I 26.3%, II 33.7%, III 17.9%, and IV 4.2%. Independent risk factors for IAH were alcoholic cirrhosis (p = 0.01), West-Haven score (p = 0.01), and PaO2/FiO2 ratio (p = 0.02); as well as infection (p = 0.048) for ACS. Overall, 28-day mortality was 52.6% associated with higher IAP and ACS, and independent risk factors were MELD (p = 0.001), white blood cell count (p = 0.03), PaO2/FiO2 ratio (p = 0.03), and lactate concentration (p = 0.04) at ICU admission. This study demonstrates a very high prevalence of IAH/ACS in the critically ill cirrhotic patient in intensive care. Increased IAP and ACS were associated with severity of disease and adverse outcomes and independent risk factors for IAH were alcoholic cirrhosis, hepatic encephalopathy and PO2/FiO2 ratio, as well as infection for ACS. Early diagnosis, prevention, and treatment of IAH/ACS might improve outcome in critically ill cirrhotic patients.
Sections du résumé
BACKGROUND
Liver cirrhosis and ascites are risk factors for intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS); however, data is scarce. We aimed to determine the prevalence of IAH/ACS in a population of critically ill cirrhotic patients with acute medical illness in intensive care and to assess for risk factors and clinical outcomes.
METHODS
This was a multicentric retrospective cohort study including two general ICUs and pooled data from a multicentric study between January 2009 and October 2019.
RESULTS
A total of 9,345 patients were screened, and 95 were included in the analysis. Mean age was 56.7±1.3 years, and 79% were male. Liver cirrhosis etiology included alcohol in 45.3% and alcohol plus hepatitis C virus in 9.5%. Precipitating events included infection in 26% and bleeding in 21% of cases. Mean severity score MELD and SAPS II were 26.2±9.9 and 48.5±15.3, respectively, at ICU admission. The prevalence of IAH and ACS was respectively 82.1% and 23.2% with a mean value of maximum IAP of 16.0±5.7 mmHg and IAH grades: absent 17.9%, I 26.3%, II 33.7%, III 17.9%, and IV 4.2%. Independent risk factors for IAH were alcoholic cirrhosis (p = 0.01), West-Haven score (p = 0.01), and PaO2/FiO2 ratio (p = 0.02); as well as infection (p = 0.048) for ACS. Overall, 28-day mortality was 52.6% associated with higher IAP and ACS, and independent risk factors were MELD (p = 0.001), white blood cell count (p = 0.03), PaO2/FiO2 ratio (p = 0.03), and lactate concentration (p = 0.04) at ICU admission.
CONCLUSIONS
This study demonstrates a very high prevalence of IAH/ACS in the critically ill cirrhotic patient in intensive care. Increased IAP and ACS were associated with severity of disease and adverse outcomes and independent risk factors for IAH were alcoholic cirrhosis, hepatic encephalopathy and PO2/FiO2 ratio, as well as infection for ACS. Early diagnosis, prevention, and treatment of IAH/ACS might improve outcome in critically ill cirrhotic patients.
Identifiants
pubmed: 33984016
doi: 10.1371/journal.pone.0251498
pii: PONE-D-21-05197
pmc: PMC8118291
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0251498Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9
pubmed: 23474284
Hepatology. 2001 Feb;33(2):464-70
pubmed: 11172350
Ann Intensive Care. 2017 Dec;7(1):33
pubmed: 28321803
Ann Intensive Care. 2018 Jul 6;8(1):78
pubmed: 29980962
J Multidiscip Healthc. 2019 Dec 19;12:1061-1074
pubmed: 31908470
Med Sci Monit. 2007 Dec;13(12):CR548-54
pubmed: 18049434
Rev Bras Ter Intensiva. 2020 Mar;32(1):49-57
pubmed: 32401978
J Hepatol. 2016 Mar;64(3):717-35
pubmed: 26519602
Liver Int. 2019 Jul;39(7):1271-1280
pubmed: 30825255
J Trauma Acute Care Surg. 2012 Jan;72(1):183-8
pubmed: 22002620
BMC Gastroenterol. 2014 Jan 27;14:18
pubmed: 24467993
Intensive Care Med. 2019 Dec;45(12):1703-1717
pubmed: 31664501
World J Emerg Surg. 2015 May 30;10:22
pubmed: 26056530
Intensive Care Med. 2004 May;30(5):822-9
pubmed: 14758472
Crit Care. 2020 Mar 24;24(1):97
pubmed: 32204721
Crit Care Med. 2005 Feb;33(2):315-22
pubmed: 15699833
Intensive Care Med. 2007 Jun;33(6):951-62
pubmed: 17377769
Crit Care Med. 2019 Apr;47(4):535-542
pubmed: 30608280
Intensive Care Med. 2013 Jul;39(7):1190-206
pubmed: 23673399
Hepatology. 2003 Jul;38(1):258-66
pubmed: 12830009
J Hepatol. 2010 Sep;53(3):397-417
pubmed: 20633946
J Hepatol. 2014 Nov;61(5):1038-47
pubmed: 24950482
PLoS One. 2018 Mar 14;13(3):e0193654
pubmed: 29538440
Crit Care. 2010;14(2):R31
pubmed: 20230612
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Hepatology. 2000 Apr;31(4):864-71
pubmed: 10733541
Acta Neurochir (Wien). 2019 May;161(5):855-864
pubmed: 30911831
J Crit Care. 2011 Jun;26(3):257-61
pubmed: 21036523
CMAJ. 2010 Dec 14;182(18):1971-7
pubmed: 21059778
Crit Care. 2008;12(1):R4
pubmed: 18197961
GE Port J Gastroenterol. 2018 Jan;25(1):18-23
pubmed: 29457046
Crit Care Med. 2001 Jul;29(7):1466-71
pubmed: 11445709
Curr Opin Crit Care. 2011 Apr;17(2):165-9
pubmed: 21326095
Acta Clin Belg. 2007;62 Suppl 1:89-97
pubmed: 24881705
J Cereb Blood Flow Metab. 2016 Aug;36(8):1338-50
pubmed: 27174995
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Intensive Care Med. 2006 Nov;32(11):1722-32
pubmed: 16967294
N Engl J Med. 2008 Sep 4;359(10):1018-26
pubmed: 18768945
Ann Intensive Care. 2012 Jul 5;2 Suppl 1:S4
pubmed: 22873420
Intensive Care Med. 2005 Nov;31(11):1577-81
pubmed: 16193329